Post on 09-Oct-2020
Presented for: Governance
Presented by:Clare Smith
Chief Operating Officer
Author: Information Department
Previous Committees: None
Trust Goals
The best for patient safety, quality and experience ✓
The best place to work ✓
A centre for excellence for research, education and innovation ✓
Seamless integrated care across organisational boundaries ✓
Financial sustainability ✓
Key points
This report is presented to ensure the Board remains up-to-date with the areas the Trust is not achieving performance against the NHS Improvement(NHSI) frameworks, as well as measures stipulated within the NHS Standard Contract.
Governance
Quality & Performance Report
Public Board
September 2019
Agenda Item 12.1 (i)
1
2
Table of ContentsPerformance Summary Page 4,5
Non-Performing
Referral to Treatment Page 7
Emergency Care Standard Page 8
Delayed Transfer of Care and Repatriations Page 9
Diagnostic Test Waiting Time Page 10
Cancelled Operations Page 11
2 Week Cancer Waiting Times Page 12
31 Day Cancer Waiting Times Page 13
62 Day Cancer Waiting Times Page 14
Ambulance Handover Page 15
Incidence of MRSA Page 16
Incidents Page 17
Venous Thromboembolism (VTE) Risk Assessments Page 18
Performing
Mortality Indicator Reporting Page 20
Incidence of CDI Page 21
Electronic Discharge Advice Notes (eDANs) Page 22
Complaints Page 23
Patient satisfaction: Friends and Family Test Page 24
Harm Free Care Page 25/26
Outpatient Measures Page 27
Length of Stay Page 28
30 Day Emergency Readmission Rates Page 29
CQUIN Tracker Page 30/31/32
People Page 33/34
Finance
Finance: Accountability Framework Dashboard Page 35
Finance: In-year Delivery Page 36
Appendices
Appendix 1: Updates from Regulators Page 37
Appendix 2: Peer Groups Page 38
Appendix 3: Glossary Page 39
3
SummaryPerforming Non-Performing
Responsive • Outpatient Measures
• 31 Day Cancer First Definitive Treatment
• 31 Day Cancer Subsequent Drug Treatment
• 31 Day Cancer Subsequent Radiotherapy
• Referral to Treatment
• Emergency Care Standard
• Delayed Transfer of Care and Repatriations
• Diagnostic Test Waiting Times
• Cancelled Operations
• 2 Week Cancer Waiting Times
• 31 Day Cancer Subsequent Surgery
• 62 Day Cancer Waiting Times
• Ambulance Handover
Safe • Incidence of CDI
• Electronic Discharge Advice Notes (eDANs)
• Incidence of MRSA
• Incidents
• Venous Thromboembolism (VTE) Risk Assessments
Effective • Mortality Indicator Reporting
• 30 Day Emergency Readmission Rates
• Harm Free Care
Caring • Complaints
Well-Led • Patient Satisfaction: Friends and Family Test
• People
Other • Length of Stay
• CQUIN Tracker
Performance Summary
4
Performance Summary
5
Performance Measures Target Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19
Section C - NHSE Quality and Contract Requirements
Serious Incidents (SUIs) - 3 8 8 11 14 12 11 15 5 11 11 10
HCAI: MSSA <=59 8 8 5 10 7 3 6 10 5 6 8 3
Gynae Cytology 14 Day TATs >=98 0.29 0.32 0.51 0.45 2.87 0.79 0.67 1.40 1.04 -
Harm Free Care >=95 95.46 94.43 95.88 95.78 93.87 93.84 95.69 96.33 96.58 95.32 95.76 96.56
Readmissions to PICU Within 48 Hours <1 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.01 0.00 0.00 0.00
Section D - Local Quality and Contract Requirements
Cancer: 62 Day: Consultant Upgrade >=85 56.0 52.8 70.0 73.6 68.4 64.4 70.0 79.4 65.5 68.0 89.1
OP FUP Backlog: More Than 3 Months Overdue - 5,124 4,862 4,896 5,716 4,946 5,299 6,214 6,431 7,089 6,994 8,708 9,801
OP FUP Backlog: More Than 12 Months Overdue - 79 98 73 96 123 132 135 142 164 155 166 196
Section E - Internal Monitoring
Dementia Performance: Stage 1 >=90 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Dementia Performance: Stage 2 >=90 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Dementia Performance: Stage 3 >=90 91.67 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Pressure Ulcers (Grade 3) (developed) - 4 8 4 6 8 3 3 4 3 3 5 1
Pressure Ulcers (Grade 4) (developed) - 0 0 1 0 1 1 1 0 0 0 0 0
OP Appts Cancelled 2 or More Times (Total) - 2,026 2,336 2,214 2,024 2,602 2,125 2,324 2,301 2,519 2,302 2,639 2,404
OP Appts Cancelled 2 or More Times (By Hospital) - 882 993 951 854 1,093 956 1,096 1,062 1,118 918 1,134 977
Non performing areas
6
7
CQC: Responsive Referral to Treatment Waiting Times
Standard(s): Ensure that a minimum of 92% of patients on incomplete pathways have been waiting no more than 18 weeksEnsure no patients wait over 52 weeks from referral to treatment
Owner(s): Chief Operating Officer and Clinical Directors
Commentary: The RTT reported position for August is 84.09%, a drop of 1.79% from July 2019.The TWL is currently 63,134 patients (against a trajectory of 65,727) and is expected to continue reducing over the remainder of the year.The reduction in RTT performance has been caused by the growth in non-admitted patients who have waited over 18 weeks. This is as a result of challenges in some specialties toaccommodate the rapid increase in referral numbers experienced between December 2018 and May 2019. These longer waits are associated with a small number of high volume specialties.Additional clinic capacity and alternative providers have been identified in a number of specialties to address this growth where possible. Actions taken to arrest this growth have exacerbatedthe reduction in performance as they have impacted on the denominator, but they are the right actions to take.There were 82 patients who waited over 52 weeks for treatment at the end of August 2019, with 81 patients in Adult Spines and 1 patient in Colorectal following the cancellation of theirplanned surgery due to Silver Command at the end of the month.A spinal summit will be held on 24th September bringing together LTHT, commissioners and NHSE/I to discuss the action plan to improve this position and the risks to delivery
Incomplete RTT performance
by reporting specialty, Aug-19Pathways Breaches Performance Monthly Trend
Cardiology 2,546 6 99.76%
Cardiothoracic Surgery 339 27 92.04%
Dermatology 3,812 463 87.85%
Ear Nose & Throat 1,872 431 76.98%
Elderly Medicine 144 0 100.00%
Gastroenterology 1,159 51 95.60%
General Medicine 1 0 100.00%
General Surgery 1,168 171 85.36%
Gynaecology 4,259 396 90.70%
Neurology 1,652 0 100.00%
Neurosurgery 321 44 86.29%
Ophthalmology 4,407 240 94.55%
Oral Surgery 1,510 147 90.26%
Plastic Surgery 2,031 446 78.04%
Respiratory Medicine 1,147 91 92.07%
Rheumatology 2,547 253 90.07%
Trauma & Orthopaedic Surgery 5,799 2,077 64.18%
Urology 3,241 954 70.56%
Other Specialties 25,179 4,248 83.13%
Trust 63,134 10,045 84.09%
0
1000
2000
3000
4000
5000
6000
7000
8000
Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19
Incomplete Pathway Breach Date Passed
Outpatient Inpatient
65%
70%
75%
80%
85%
90%
95%
100%
Trusts
Peer comparison: % of patients on incomplete RTT pathways waiting no more than 18 weeks, July 2019
LTHT Peers Other Trusts England Target
Source: NHS England
0
10,000
20,000
30,000
40,000
50,000
60,000
70,000
80%
82%
84%
86%
88%
90%
92%
94%
96%
98%
100%
Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19
% of patients on incomplete RTT pathways waiting no more than 18 weeks
Breaches Total pathways % within 18 weeks Standard
CQC: Responsive Emergency Care Standard
Standard(s): Ensure at least 95% of attendees to A&E are admitted, transferred or discharged within 4 hours of arrival
Owner(s): Chief Operating Officer and Clinical Director of Urgent Care
Commentary: The NHSI trajectory target for August 2019 was 89.3%; LTHT achieved 88.28%. This is the best monthly reported position to date in 2019/20. LTHT was on trajectory to
achieve 89.3% up until Friday 23rd August. The impact of the bank holiday weekend exceeded what was anticipated. LTHT experienced an extended recovery period resulting
in the Trust being in Silver Command for four days. LTHT has reduced its bed base on the SJUH site by 36 beds over the last year and whilst compensated slightly by the
reduction in super stranded, there has been a loss of resilience.
An additional 1,112 patients attended LGI & SJUH in August 2019 compared to August 2018 (6.49% increase). Despite being below trajectory, LTHT’s August 2019
performance was 0.75% better than performance in August 2018, whilst maintaining a position of zero 12 hour breaches and zero patients being cared for in non-designated
areas.
Delivery against the Recovery Plan is managed through the Unplanned Care Improvement Programme. LGI non-admitted performance in August 2019 was 96.13%; at SJUH
non-admitted performance was 93.15%. LTHT overall non-admitted performance was 94.99%.
850%
55%
60%
65%
70%
75%
80%
85%
90%
95%
100%
Trusts
Peer comparison: Performance against the 95% 4 hour A&E access standard; August 2019
(Type 1 Departments - Major A&E)LTHT Peers Others Target
Source: NHS England
0
1000
2000
3000
4000
5000
6000
7000
0
5000
10000
15000
20000
25000
30000
Bra
che
s
Att
en
da
nce
s
Monthly Attendances and Breaches of the 4 Hour Access Standard
Attendances Breaches Allowed Breaches
60
65
70
75
80
85
90
95
100
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52
Pe
rfo
rman
ce (%
)
Week Number
Weekly ECS Performance2016-17 2017-18 2018-19 2019-20 Target
Site Aug-19 YTD
St James's 7,442 36,540
LGI 9,433 49,842
GP Stream 1,378 7,252
WGH 2,378 12,343
SHK 4,228 16,781
Trust 24,859 122,758
St James's 1,821 8,953
LGI 1,089 6,300
GP Stream 0 0
WGH 2 37
SHK 0 0
Trust 2,912 15,290
St James's 75.5% 75.5%
LGI 88.5% 87.4%
GP Stream 100% 100%
WGH 100% 100%
SHK 100% 100%
Trust 88.3% 87.5%
Indicator
Attendances
Breaches
Performance
> 95%
CQC: Responsive Delayed Transfer of Care and Repatriations
Standard(s): To reduce the length of stay in order to release capacity for other patients and provide an improved patient experience
Owner(s): Chief Operating Officer and Clinical Directors
Commentary: • From April 2017 to March 2018 LTHT lost 24,557 beds days due to DTOCs, this was equivalent to 67.3 beds not available for patient care, which is up from 64.8 beds in the previous year. For 2018/19 LTHT has lost 16,299 bed days which equates to 44.7 beds not available for patient care. During April - August 2019 LTHT lost 5083 bed days which equates to 33.2 beds demonstrating an improvement on the previous year. The largest category of delays was and continues to be Code G - NHS patient or Family choice.
• LTHT is working with partners following the diagnostic carried out by Newton Europe in June 2018 which demonstrated that 56% of people leaving hospital did not achieve their ideal outcome. A re audit in the summer of 2019 demonstrated an improvement with 41% of people leaving hospital not achieving their ideal outcome. Both audits suggest that we have an opportunity to increase the independence of service users, with many ending up in a more intensive care setting than they required.
• Since the diagnostic LTHT has worked with system partners to develop a programme of work focussing on the right pathway every time and responsive community services.
9
0
200
400
600
800
1,000
1,200
1,400
1,600
1,800
Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19
Delayed Transfers of Care: bed days lost, by month and delay source
NHS Social Services
0
50
100
150
200
250
300
Jun-17
Jul-1
7
Aug
-17
Sep
-17
Oct-
17
Nov-1
7
Dec-1
7
Jan-18
Fe
b-1
8
Ma
r-1
8
Apr-1
8
Ma
y-18
Jun-18
Jul-1
8
Aug
-18
Sep
-18
Oct-
18
Nov-1
8
Dec-1
8
Jan-19
Fe
b-1
9
Ma
r-1
9
Apr-1
9
Ma
y-19
Jun-19
Jul-1
9
Aug
-19
Number of Patients MFFD Monthly Snapshot Audit
CQC: Responsive Diagnostic Test Waiting Times
Standard(s): Ensure at least 99% of patients wait no more than 6 weeks for a diagnostic test
Owner(s): Chief Operating Officer and Clinical Directors
Commentary: The diagnostic standard was consistently delivered 99% from September 2016, with the exception of January and December 2018 where LTHT did not achieve the standard due to reduced capacity over the Christmas & New Year periods. Since April 2019, the standard has not been achieved for a period of five months.Service delivery in August 2019 is at 98.83% which is 0.17% below the required standard of 99%. This 0.17% represents a total of 18 breaches of the 6 week standard. August position is a 0.5% improvement on July’s position. Underlying issues:• Replacement of the Bexley Wing scanner from March-June 2019. • CAH replacement scanner (University/ Leeds Cares joint funded) over the same period.• New Paediatric Hybrid MRI scanner not becoming fully operational until May (for Radiology MRI use). • Radiology staffing shortfalls
Number of
Patients on
Waiting List
Number Waiting
over 6 Weeks
% Waiting Less
Than 6 Weeks
- - 99%
Colonoscopy 202 2 99.0%
Flexi sigmoidoscopy 56 0 100.0%
Cystoscopy 141 1 99.3%
Gastroscopy 232 6 97.4%
Magnetic Resonance Imaging 2,542 94 96.3%
Computed Tomography 2,009 31 98.5%
Non-obstetric ultrasound 5,068 17 99.7%
Barium Enema 0 0 -
DEXA Scan 736 1 99.9%
Audiology - Audiology Assessments 179 0 100.0%
Cardiology - echocardiography 1,445 0 100.0%
Cardiology - electrophysiology 0 0 -
Neurophysiology - peripheral neurophysiology 344 0 100.0%
Respiratory physiology - sleep studies 262 2 99.2%
Urodynamics - pressures & flows 0 0 -
13,216 154 98.8%
Diagnostic Test
Target
Trust
Endoscopy
Imaging
Physiological
Measurement
Waiting list position as at 31-Aug-19
0
2,000
4,000
6,000
8,000
10,000
12,000
14,000
16,000
Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19
Diagnostic waits: number of patients waiting for a diagnostic test at month end
90%
92%
94%
96%
98%
100%
Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19
Diagnostic waits: % patients waiting less than 6 weeks at month end
% Within 6 Weeks Target
10
80%
85%
90%
95%
100%
Trusts
Diagnostic waits - % of patients waiting less than 6 weeks at month-end, Jul-19
LTHT Peers Other Trusts England Target
Source: NHS England
CQC: Responsive Cancelled Operations
Standard(s): Ensure all patients who have operations cancelled at the last minute, for non-clinical reasons are offered another binding date to be treated within a maximum of 28 days (zero tolerance standard)
Owner(s): Chief Operating Officer and Clinical Directors
Commentary: This is a zero tolerance NHS contract standard and is reportable on a quarterly basis.
The volume of 28 day breaches has continued to reduce and remain below the mean of 23. The lowest monthly figure since October 2017 has been reported in June 2019.
For Q1 there were a total of 46 reported 28 day breaches in comparison to the same period last year of 82. Further work continues at CSU level to achieve the zero standard as part of CSU delivery contracts and there will be an increased focus on specific high volume CSU’s with an aim to further reducing the number of breaches against this standard.
11
Assessment in Progress
0%
5%
10%
15%
20%
25%
30%
35%
Trusts
% of patients not treated within 28 days of last minute cancellations for non-clinical reasons
- Quarter 1, 2019-20 (April to June 2019)
LTHT Peers Others England
Source: NHS England
0
10
20
30
40
50
60
70
0 100 200 300 400 500 600 700 800 900
Pa
tie
nts
no
t tr
ea
ted
wit
hin
28 d
ays a
s a
Pe
rce
nta
ge
of
Ca
nce
lati
on
s fo
r n
on
cli
ncia
l re
aso
ns
Number of last minute elective operations cancelled for non clinical reasons
Patients not treated within 28 days of last minute cancellations for non-clinical reasons, Quarter 1, 2019-20
Average
2SD limits
3SD limits
LTHT
Other Trusts
Source: NHS England
497
559
454
383
48
95 102
46
0
100
200
300
400
500
600
700
Q2 Q3 Q4 Q1
Quarterly Comparison of Last Minute Cancellations and Breaches of the 28 Day Standard
No. of LMCO in theQtr
No. of LMCO in thePrevious Years Qtr
No. of Breaches in theQtr
No. of Breaches in thePrevious Years Qtr
CQC: Responsive 2 Week Cancer Waiting Times
Standard(s): Ensure at least 93% of patients urgently referred with suspected cancer by their GP (GMP or GDP) are seen within 14 daysEnsure at least 93% of patients urgently referred for evaluation/investigation of “breast symptoms” by a primary or secondary care professional are seen within 14 days
Owner(s): Chief Operating Officer
Commentary: A 13% improvement in performance was reported in July although LTHT did not deliver the NHSE trajectory or constitutional standard with overall performance of 90.4%.An 8% growth in referrals was anticipated when the NHS Improvement trajectory was devised and this was broadly in line with actual volumes in Q1. However LTHT received the highestvolume of 2ww referrals in July with 545 additional referrals being received than that of the previous month. This constitutes a 20% increase in referral demand from July 2018. Increaseddemand within the skin, breast, head and neck and lower GI services in particular impacted on the Trust’s ability to meet the standard.Despite increased demand in the Breast service in July, the Breast service was able to clear the backlog of 2ww referrals through additional outpatient clinics and breast imaging to the pointwhere breast 2ww delivery for July was reported at 92.3%, which is the highest performance since October 2018.Although the constitutional standard was achieved in the skin service, a 4% reduction in performance was reported. As skin referrals form 30% of all 2WW referrals, this impacted on recoveryof the overall standard. 987 2ww skin referrals were received in July, the highest volume LTHT has reported (213 more than the previous month). Skin referral demand grew by 27% in July2019 when compared with July 2018. The service has been able to respond positively to this demand with August 2ww performance in the skin service expected to be reported above 96%.
12
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Q2 2018/19 Q3 2018/19 Q4 2018/19 Q1 2019/20 Q2 2019/20(as at Jul-19)
Performance against the 2 week cancer standards
Suspected cancer Breast symptoms Threshold
60
65
70
75
80
85
90
95
100
0 1000 2000 3000 4000
See
n W
ithin
14
days
as
a P
erce
ntag
e of
Tot
al S
een
Total Seen
Cancer Benchmarking - 2 Week Wait, July 2019
Average
2SD limits
3SD limits
LTHT
Other Trusts
Source: NHS England
Tumour Type Jul-19 (%)Total Patients
Seen
Patients Seen
within Target
Suspected brain or central nervous system tumours 100.0% 12 12
Suspected breast cancer 92.3% 666 615
Suspected children's cancer 95.0% 20 19
Suspected gynaecological cancers 95.9% 242 232
Suspected haematological malignancies excluding acute leukaemia 85.0% 20 17
Suspected head and neck cancers 89.5% 370 331
Suspected lower gastrointestinal cancers 82.2% 490 403
Suspected lung cancer 82.9% 35 29
Suspected other cancer - 0 0
Suspected sarcomas 20.0% 10 2
Suspected skin cancers 93.0% 988 919
Suspected testicular cancer 100.0% 9 9
Suspected upper gastrointestinal cancers 88.9% 208 185
Suspected urological cancers (excluding testicular) 90.7% 236 214
Trust 90.4% 3,306 2,987
Cancer 2 Week Waits - Breast Symptoms 90.3% 154 77
Cancer 2 Week Waits - Suspected
CQC: Responsive 31 Day Cancer Waiting Times
Standard(s): Ensure at least 93% of patients urgently referred with suspected cancer by their GP (GMP or GDP) are seen within 14 days
Ensure at least 93% of patients urgently referred for evaluation/investigation of “breast symptoms” by a primary or secondary care professional are seen within 14 days
Owner(s): Chief Operating Officer
Commentary: The 31 Day First Definitive was achieved in April, June and July, with July performance of 96.6%. The standard was not achieved in May due to an increase in urology breaches as a consequence of increased demand with inadequate elective capacity to treat within target.
31 Day Subsequent Treatments - Of the 1041 patients receiving surgical, radiotherapy or drug subsequent treatments in July, 1028 were treated within 31 days in line with the constitutional standard. Of the 13 breaches, 12 were on a surgical pathway (of the 177 treated surgically) and therefore the 31 day Subsequent Surgery standard was 0.8% below the standard in July predominantly due to limited capacity within the bladder and skin service.
LTHT continues to meet the Subsequent Drug and Radiotherapy treatment standards.
13
90%
92%
94%
96%
98%
100%
Q2 2018/19 Q3 2018/19 Q4 2018/19 Q1 2019/20 Q2 2019/20(as at Jul-19)
Performance against the 31 day cancer standard for first treatments
85%
90%
95%
100%
Q2 2018/19 Q3 2018/19 Q4 2018/19 Q1 2019/20 Q2 2019/20(as at Jul-19)
31 day cancer standard for second or subsequent treatment Drug Surg RT
Tumour Type Jul-19 (%)Total Patients
Seen
Brain/Central Nervous System 100.0% 10
Breast 100.0% 64
Childrens cancer 100.0% 8
Gynaecological 100.0% 41
Haematological 100.0% 40
Head and Neck 91.7% 48
Lower Gastrointestinal 94.6% 56
Lung 97.6% 83
Other 100.0% 6
Sarcoma 100.0% 11
Skin 95.7% 47
Upper Gastrointestinal 96.1% 51
Urological 93.7% 95
Trust 96.6% 560
Cancer 31 Day Waits - Subsequent Surgery 93.2% 177
Cancer 31 Day Waits - Subsequent Drug Treatment 100.0% 369
Cancer 31 Day Waits - Subsequent Radiotherapy 99.8% 495
Cancer 31 Day Waits - First Definitive Treatment
60
65
70
75
80
85
90
95
100
0 100 200 300 400 500 600
Seen
With
in 3
1 da
ys a
s a
Perc
enta
ge o
f Tot
al S
een
Total Seen
Cancer Benchmarking - 31 Day First Treatment, July 2019
Average
2SD limits
3SD limits
LTHT
Other Trusts
Source: NHS England
CQC: Responsive 62 Day Cancer Waiting Times
Standard(s): Ensure at least 85% of patients receive their first definitive treatment for cancer within 62 days of an urgent GP (GDP or GMP) referral for suspected cancer
Ensure at least 90% of patients receive their first definitive treatment for cancer within 62 days of referral from an NHS cancer screening service
Owner(s): Chief Operating Officer
Commentary: • July reported performance at 70.0%. This was a 0.4% improvement on June’s position of 69.6%.• Although the number of 62 day patients treated per working day increased slightly when compared to June, this was not sufficient to meet increased demand with a high volume of
breaches in urology, lung and lower GI and an increase in the volume of gynaecology and haematology breaches due to late referrals and patients requiring input from multiplespecialties. Only 46% of external patients treated in July were sent to LTHT by day 38.
• The number of patients awaiting treatment over day 62 in their pathway reduced from 242 in June to 160 in July, although this has increased over the summer with a current September
backlog of 199 patients (32 of these patients were sent to LTHT after day 62 of their pathway). Twice weekly review at individual patient level has commenced between the key CSUs andthe lead cancer team focused on actions to progress individual patients. Actions to recovery delivery will also be agreed through Level 1 and Level 2 escalation meetings with ADOP andDCOO.
14
Tumour Type Jul-19 (%)Total Patients
Seen
Acute Leukaemia 100.0% 0.5
Brain/Central Nervous System - 0.0
Breast 83.8% 37.0
Childrens cancer - 0.0
Gynaecological 73.8% 21.0
Haematological (Excluding Acute Leukaemia) 44.4% 13.5
Head and Neck 58.0% 25.0
Lower Gastrointestinal 62.9% 17.5
Lung 75.0% 12.0
Other 50.0% 1.0
Sarcoma 57.1% 3.5
Skin 93.8% 32.0
Testicular 100.0% 3.0
Upper Gastrointestinal 46.4% 14.0
Urological (Excluding Testicular) 63.6% 53.5
Trust 70.0% 233.5
Cancer 62 Day Waits - GP Referral
0
10
20
30
40
50
60
70
80
90
100
0 50 100 150 200 250
See
n W
ithin
62
days
as
a P
erce
ntag
e of
Tot
al S
een
Total Seen
Cancer Benchmarking - 62 Day GP/Dentist, July 2019
Average
2SD limits
3SD limits
LTHT
Other Trusts
Source: NHS England
% of IPTs received
by day 38, Jul-19Trajectory By day 38 Total % by day 38
Airedale 70% from Apr-15 3 5 60.0%
Bradford 85% from May-15 5 13 38.5%
Calderdale 85% from Dec-14 9 14 64.3%
Harrogate 85% from Dec-14 7 12 58.3%
Mid Yorks 85% from end Q3 14/15 9 20 45.0%
York 75% by end Q4 14/15 7 17 41.2%
Sub Total 85% 40 81 49.4%
Total 85% 41 84 48.8%
60%
70%
80%
90%
100%
Q2 2018/19 Q3 2018/19 Q4 2018/19 Q1 2019/20 Q2 2019/20(as at Jul-19)
Performance against the 62 day cancer standard for GP/dentist referralsAll referrals Threshold
Internal referrals By Day 38
CQC: Responsive Ambulance Handover
Standard(s): All handovers should take place within 15 minutes
Owner(s): Chief Operating Officer and Clinical Director of Urgent Care
Commentary: Handover data is recorded by YAS staff on YAS software and submitted to NHSI/E directly. The ability for LTHT validation and challenge pre National submission ceased in November 2018. LTHT continue to locally validate the position and highlighted through to the CCG’s. Since the process for excluding challenges has changed, LTHT has seen a reduction in ambulance handover performance.
15
0
10
20
30
40
50
60
70
80
Jul-18 Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19
LGI Ambulance Handover Times
>= 60 mins >= 30 mins
0
20
40
60
80
100
120
140
160
180
Jul-18 Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19
SJUH Ambulance Handover Times
>= 60 mins >= 30 mins
0
50
100
150
200
250
300
Trust Ambulance Handover Times
>= 60 mins >= 30 mins
0%
5%
10%
15%
20%
25%
30%
35%
40%
Ambulance Handover % Longer Than 15 Minutes SJUH LGI
CQC: Safe Incidence of MRSA
Standard(s): Eliminate Trust-apportioned MRSA bacteraemia cases
Owner(s): Chief Medical Officer, Infection Control Team, and Clinical Directors
Commentary: For July 2019 there have been 0 cases attributed to LTHT. The total number of cases recorded for Q1 is 1 in comparison to 2 in Q1 last year.
The key finding from LTHT’s investigation is around the use of the appropriate decolonisation when a patient has resistance to Mupirocin (nasal treatment). The Trust is continuing with the HCAI faculty work on reducing bloodstream infections and have rolled out Trust wide “know your data” and “ Personal Protective Equipment” posters to encourage IPC practices.
16
0
1
2
3
4
Trusts
Rate of trust-apportioned MRSA bacteraemia cases per 100,000 occupied bed days, Jul-18-Jul-19
Peers Other Trusts LTHT England
Source: Public Health England
44 Trust(s) reported no MRSA cases for the period. Rates calculated using 2018/19 bed day data.
0
1
2
3
0 200000 400000 600000 800000R
ate
pe
r 100000 B
ed
Da
ys
Calculated Bed Days
MRSA Benchmarking, July 2018 - July 2019
Average
2SD limits
3SD limits
LTHT
Other Trusts
Source: NHS England
MRSA by CSU Aug-19 YTD
Abdominal Medicine and Surgery 0 0
Adult Critical Care 0 0
Cardio-Respiratory 0 0
Centre for Neurosciences 0 0
Emergency and Speciality Medicine 0 1
Institute of Oncology 0 0
Trauma and Related Services 0 0
Chapel Allerton 0 0
Children's 0 0
Ear Nose & Throat 0 0
Women's 0 0
Trust 0 1
CQC: Safe Incidents
Standard(s): The number of incidents occurring compared to the patients who receive our care.The number of never events, defined as serious harm to patients which should be avoided.
Owner(s): Chief Medical Officer
Commentary: A serious incident is defined where a patient, member of staff or member of the public has suffered serious injury, major permanent harm or unexpected death, or a significant near missthat may have led to serious harm (Serious Incident Framework, NHSE, March 2015). These are reported and investigated in line with the Trust’s Serious Incident Procedure (February 2016)to help us learn and take action to prevent recurrence. A detailed review of serious incidents and the associated learning from completed investigations is undertaken at the Trust’s QualityAssurance Committee.• The Trust reported 10 serious incidents to commissioners at NHS Leeds CCG in August 2019.• One Category 3 and two ungradeable pressure ulcers were reported to the commissioners in August 2019.• Three patient falls resulting in serious injury were reported to the commissioners in August 2019.• There was one Never Event in August 2019. A wrong tooth extraction (SUI 2019/18792) in Leeds Dental Institute.
17
0
1
2
3
Never Events
0.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
Serious Incidents Per 1,000 Bed Days
*PU includes both admitted with and developed
No
. of
Inci
den
ts
0
50
100
150
200
250
300
350
400
450
500
Incidents by Risk Grade (August 2019)
Low Medium High
CQC: Safe Venous Thromboembolism (VTE) risk assessments
Standard(s): Ensure at least 95% of adult inpatients have a VTE risk assessment on admission to hospital
Owner(s): Chief Medical Officer and Clinical Directors
Commentary: Improving trajectory since current oversight system put in place (Feb 2019) 94.8% achieved for July 2019
Current actions being undertaken:1) Monthly review by clinical owner2) Work with CSUs that are below target, and with negative trajectories3) Work with wards to utilise Safety huddles for VTE review
18
50%
55%
60%
65%
70%
75%
80%
85%
90%
95%
100%
Trusts
% of eligible admitted patients risk assessed for VTE, Quarter 1 2019-20LTHT Peers Others Target
Source: NHS England
70%
75%
80%
85%
90%
95%
100%
VTE RCA Completion
90%
92%
94%
96%
98%
100%
Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19 Apr-19 May-19 Jun-19
% of eligible patients risk assessed for VTE
Performing areas
19
CQC: Effective Mortality Indicator Reporting
Standard(s): Improve the Trust’s Summary Hospital-level Mortality Indicator (SHMI) and Hospital Standardised Mortality Ratio (HSMR)
Owner(s): Chief Medical Officer and Clinical Directors
Commentary: The Trust’s SHMI for April 2018 – March 2019 was 107.75, a increase from the previous releases. Relative to other providers LTHT remains within the expected range.
Observed Deaths are above Expected Deaths for the eighth consecutive period.
The Trust is currently ranked 98 out of 130 Trusts based on Observed Deaths vs. Spells at the last SHMI publication.
20
0
20
40
60
80
100
120
140
Apr-17 to Mar-18 Jul-17 to Jun-18 Oct-17 to Sep-18 Jan-18 to Dec-18 Feb-18 to Jan-19 Mar-18 to Feb-19 Apr-18 to Mar-19
Re
lati
ve
Ris
k
Fig. 3 Trust level SHMI and HSMR (basket of 56 diagnoses) by rolling 12 month period (source: Dr Foster / HSCIC)
SHMI HSMR (faded out is provisional) National average
3500
3600
3700
3800
3900
4000
4100
4200
4300
4400
Jan-15 toDec-15
Apr-15 toMar-16
Jul-15 toJun-16
Oct-15 toSep-16
Jan-16 toDec-16
Apr-16 toMar-17
Jul-16 toJun-17
Oct-16 toSep-17
Jan-17 toDec-17
Apr-17 toMar-18
Jul-17 toJun-18
Oct-17 toSep-18
Jan-18 toDec-18
Feb-18 toJan-19
Mar-18 toFeb-19
Apr-18 toMar-19
Observed Deaths vs Expected Deaths from SHMI Publications
Observed Deaths Expected DeathsFig. 1 Trust level mortality, Apr-18 to Mar-19 Spells ValueObserved
Deaths
Expected
Deaths
95%
Confidence
Interval
125,170 107.75 4,100 3,805 89.08-112.26
60,677 106.84 2,472 2,314 102.67-111.14
SHMI published banding (95% CL with over-dispersion)
HSMR
CQC: Safe Incidence of CDI
Standard(s): Reduce the number of Trust-attributed CDIs to no more than 118
Owner(s): Chief Medical Officer and Clinical Directors
Commentary: The CDI position for August is 12 against a trajectory of no more than 19. The Trust’s position for Q1 is a total of 32 cases against a trajectory of no more than 60. It is encouraging to note that we are continuing to see a downward trend in our CDI cases following the implementation of the CDI recovery plan during Q4 of 2018/19. Actions continue to be monitored via our current HCAI Annual Programme to ensure that the changes put in place are embedded in practice.
21
0
20
40
60
80
100
120
Trusts
Rate of trust-apportioned C.Difficile cases per 100,000 occupied bed days for patients aged > 2 years, May-17-May-18
Peers Other Trusts LTHT England
Source: Public Health England
3 Trust(s) reported no CDI cases for the period. Rates calculated using 2015/16 bed day data.
0
10
20
30
40
50
60
70
80
90
0 200000 400000 600000 800000
Ra
te p
er
100000 B
ed
Da
ys
Calculated Bed Days
CDI Benchmarking, July 2018 - July 2019
Average
2SD limits
3SD limits
LTHT
Other Trus ts
Source: NHS England
CDI by CSU Aug-19 YTD
Abdominal Medicine and Surgery 4 13
Adult Critical Care 0 4
Cardio-Respiratory 1 5
Centre for Neurosciences 1 1
Chapel Allerton Hospital 0 0
Childrens 0 2
Emergency and Speciality Medicine 3 17
Head & Neck 0 0
Institute of Oncology 3 13
Trauma and Related Services 0 1
Unassigned 0 0
Womens 0 2
Trust 12 63
63Trust (accounting for cases agreed with the CCG as unavoidable)
0
50
100
150
200
250
300Progress against the CDI target (split by annual trajectories)
CDI Cases Trajectory
Other: Local Electronic Discharge Advice Notes (eDANs)
Standard(s): Ensure at least 90% of eDANs comply with requirements and are received by GPs within 24 hours
Owner(s): Chief Medical Officer
Commentary: LTHT has been achieving this standard consistently since August 2018 with a steady improvement to 91.8% in August 2019.
22
0
1,000
2,000
3,000
4,000
5,000
6,000
7,000
8,000
65%
70%
75%
80%
85%
90%
95%
100%
Aug-17
Sep-17
Oct-17
Nov-17
Dec-17
Jan-18
Feb-18
Mar-18
Apr-18
May-18
Jun-18
Jul-18
Aug-18
Sep-18
Oct-18
Nov-18
Dec-18
Jan-19
Feb-19
Mar-19
Apr-19
May-19
Jun-19
Jul-19
Aug-19
% of eDANs sent to GP within 24 hours of discharge
Applicable discharges % sent within 24 hours Target
0
1000
2000
3000
4000
5000
6000
Completed eDANs
Bluespier PPM+ Total
CQC: Caring Complaints
Standard(s): Work to reduce the number of complaints per 10,000 patient contactsReduce the number of complaints that are re-opened within 6 months of the initial response because concerns have not satisfactorily beenaddressed (internal indicator) through increasing the quality of complaint responses and reducing time to response issued.
Owner(s): Chief Nurse
Commentary: The number of complaints in August 2019 fell with the average number of complaints having risen from Feb 2019. Complaints appear to drop in the month of August with an assumption that it is holiday season and complaints are likely to rise in September as in previous years.The most frequently raised complaint in August 2019 relate to communication, treatment and administrative issues.
23
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
0
20
40
60
80
100
Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19
Number of complaints received and rate per 10,000 patient contacts
Received Rate per 10,000 patient contacts
0
5
10
15
20
25
Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19
Number of complaints re-opened
70%
75%
80%
85%
90%
95%
100%
Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19
Percentage of complaints acknowledged within 3 working days
Co
mm
un
ica
tio
n
Tre
atm
en
t
Ad
min
istr
ati
on
, a
cce
ss,
ad
mis
sio
n,
tra
nsf
er
an
d
dis
ch
arg
e
Ra
dio
log
y
Me
dic
ati
on
Ob
serv
ati
on
/mo
nit
ori
ng
Sa
feg
ua
rdin
g
He
alt
h r
eco
rds/
do
cu
me
nta
tio
n
Pa
tie
nt ca
re/n
utr
itio
n
Em
erg
en
cy D
ep
art
me
nt
Eq
uip
me
nt
Pre
ssu
re u
lce
r
0%
20%
40%
60%
80%
100%
0
5
10
15
20
25
30
35
40
Cu
mu
lati
ve
%
Co
mp
lain
ts
Subject
Complaints by Subject (Aug-19)
Vital Few Useful Many Cumulative% Cut Off % [42]
Clinical Service Unit Received (YTD) Activity Rate/ 10k Activity
Theatres & Anaesthesia 11 10,825 10.2
Centre for Neurosciences 35 36,959 9.5
Women's 39 43,153 9.0
Emergency & Specialty Medicine 95 167,886 5.7
Trauma & Related Services 23 46,687 4.9
Children's 28 69,889 4.0
Cardio-Respiratory 22 60,489 3.6
Abdominal Medicine & Surgery 52 150,137 3.5
Leeds Dental Institute 6 27,621 2.2
Oncology 33 179,637 1.8
CQC: Well-led Patient satisfaction: Friends and Family Test
Standard(s): Ensure a high proportion of eligible patients respond to the Friends and Family Test (FFT) and that the Trust achieves high recommendation rates (2015/16 thresholds have not yet been specified by the TDA)
Owner(s): Chief Nurse
Commentary: The overall Response and Recommendation Rates includes those from Outpatients, Inpatients, Day Case, Maternity and Emergency Departments. The overall response rate in August 2019 was one of the highest the Trust has recorded.The overall recommended rate in August 2019 was above 90%. Both Emergency Departments continued to perform above the Trust response rate target of 20% with 50.4% SJUH ED patients providing feedback.All Inpatient/Daycase CSUs achieved a % recommended rate higher than the internal target of 90%.
24
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19
FFT response rates (%)
A&E Inpatients Maternity
50%
55%
60%
65%
70%
75%
80%
85%
90%
95%
100%
Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19
FFT recommendations (%)
A&E Inpatients Maternity Outpatients
Response
RateRecommendation
Response
RateRecommendation
Abdominal Medicine and Surgery 61.3% 96.4% 53.3% 96.7%
Cardio-Respiratory 45.0% 97.7% 37.1% 98.1%
Centre for Neurosciences 38.6% 97.8% 32.6% 96.7%
Chapel Allerton Hospital 39.3% 99.0% 31.5% 98.9%
Children's 47.0% 97.5% 37.8% 97.0%
Emergency and Specialty Medicine 54.3% 92.4% 49.4% 92.1%
Head & Neck 65.5% 95.9% 44.1% 97.2%
Institute of Oncology 29.4% 97.0% 23.5% 96.8%
Leeds Dental Institute 132.8% 98.1% 92.9% 98.6%
Theatres & Anaesthesia 39.6% 95.6% 32.9% 96.5%
Trauma and Related Services 97.5% 97.5% 61.0% 96.7%
Women's 4.4% 100.0% 11.3% 95.1%
Inpatient Total 48.2% 96.5% 39.5% 96.3%
Maternity Total 58.1% 99.1% 47.1% 97.9%
A&E Total 35.2% 87.8% 28.8% 87.8%
Outpatients Total n/app 95.4% n/app 95.5%
Combined Total 42.2% 93.1% 34.9% 93.3%
Aug-19 YTD
CSU
CQC: Effective Harm Free Care
Standard(s): Ensure at least 95% of patients receive harm free care in relation to pressure ulcers, falls, catheter-associated urinary tract infections (CUTIs)and venous thromboembolism (VTE)
Owner(s): Chief Nurse and Clinical Directors
Commentary: Performance related to Harm Free Care has been greater than 95% for six consecutive months during Q1/Q2 2019/20, with decreases reported in all domains from Q4 2018/19.During Q1 there were seven patients reported on the safety thermometer who fell in April 2019, 12 in May 2019 and six in June 2019. Of these 25 total falls, six were a fall with harm (twodefined as moderate occurred within LTHT). There were no falls with harm reported in June 2019. This is in comparison to Q4 2018/2019 where 37 patients fell, of which nine resulted in thepatient suffering harm. Since April 2017 falls with harm have seen a statistically significant reduction of 63%, with the mean recalculated from 0.38% to 0.14%.
During Q1 the prevalence of new hospital acquired pressure ulcers reported on safety thermometer totalled 48, with 0.71% (12 patients) in April 2019, 0.92% ( 15 patients) for May and1.33% (21 patients) in June 2019. Of these hospital acquired pressure ulcers 6 were identified as category 3, and one was a category 4 with moderate/severe harm. This is in comparison toQ4 2018/19 when 15 category 3 and two category 4 moderate/severe harms were reported for patients receiving care within the Trust.
25
0%
1%
2%
3%
4%
5%
6%
Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19 Aug-19
Ulcers Falls w Harm New VTEs CUTIs
Source: Safety Thermometer
90
91
92
93
94
95
96
97
98
% H
arm
Fre
e
Safety Thermometer - Harm Free Care Target (95%) Harm Free Care
90%
91%
92%
93%
94%
95%
96%
97%
98%Safety Thermometer - Harm Free Care
% Avg LCL UCL
CQC: Effective Harm Free Care
Standard(s): Ensure at least 95% of patients receive harm free care in relation to pressure ulcers, falls, catheter-associated urinary tract infections (CUTIs)and venous thromboembolism (VTE)
Owner(s): Chief Nurse and Clinical Directors
Commentary: • The Trust ‘Pressure Ulcer Collaborative’ remains active and the City Wide Pressure Ulcer Prevention Group continue to meet quarterly.• September 2019 has seen a change to Datix reporting for pressure ulcers, as a result of NHSi changes to definitions.• The online level 1 eLearning for pressure ulcer training compliance is currently at 91% (green) with level 2 learning currently at 76 % (amber). The eLearning package for level 2 is in the
final draft and should be ready for rollout in Q3 across the Trust. This is expected to improve compliance levels further and allow for easier access to training via the online training ratherthan a face to face competency.
• An SSKIN week to promote pressure ulcer awareness was organised by Tissue Viability in Beckett Wing.• The hybrid mattress trial continues on 2 wards
• The Trust ‘Falls Collaborative’ remains active along with a Trust Falls Prevention Group.• As part of the actions to reduce falls, a roll out programme for Stop the Line document for non STEIS reportable falls with moderate harm has been completed. Stop the Line focusses on
bringing key members of the multi-disciplinary team together at the bedside within six hours of detection of the incident to review the circumstances of the fall. If the fall is deemed avoidable then a full root cause analysis investigation will be undertaken. This will aid learning from incidents in a timely manner.
• The Senior Nurse for Patient Safety regularly reviews training compliance for falls prevention priority training and, where requested, undertakes bespoke training within CSU’s. Current compliance is 86% (green).
26
0
50
100
150
200
250
300
350
Ap
r-1
4
Jun-1
4
Au
g-1
4
Oct
-14
De
c-1
4
Fe
b-1
5
Ap
r-1
5
Jun-1
5
Au
g-1
5
Oct
-15
De
c-1
5
Fe
b-1
6
Ap
r-1
6
Jun-1
6
Au
g-1
6
Oct
-16
De
c-1
6
Fe
b-1
7
Ap
r-1
7
Jun-1
7
Au
g-1
7
Oct
-17
De
c-1
7
Fe
b-1
8
Ap
r-1
8
Jun-1
8
Au
g-1
8
Oct
-18
De
c-1
8
Fe
b-1
9
Ap
r-1
9
Jun-1
9
Au
g-1
9
Fa
lls
Month
All Falls
0
10
20
30
40
50
60
70
80
90
100
Apr-
14
Jun-1
4
Aug
-14
Oct-
14
Dec-1
4
Fe
b-1
5
Apr-
15
Jun-1
5
Aug
-15
Oct-
15
Dec-1
5
Fe
b-1
6
Apr-
16
Jun-1
6
Aug
-16
Oct-
16
Dec-1
6
Fe
b-1
7
Apr-
17
Jun-1
7
Aug
-17
Oct-
17
Dec-1
7
Fe
b-1
8
Apr-
18
Jun-1
8
Aug
-18
Oct-
18
Dec-1
8
Fe
b-1
9
Apr-
19
Jun-1
9
Aug
-19
Pre
ss
ure
Ulc
ers
Month
Developed Pressure Ulcers
CQC: Responsive Outpatient Measures
Standard(s): Ensure the Trust’s Did Not Attend (DNA) rate is below the peer averageReduce the number of appointments cancelled by hospital within 6 weeks of appointmentReduce the number of appointments cancelled by patient within 6 weeks of appointment
Owner(s): Director of Informatics and Clinical Directors
Commentary: Non Attendance rates (DNAs) for LTHT continue to be below our peer average and achieve the set standard. This is due to the continued use of LTHT automated Outpatient appointment reminder service managed by the RBS and the offering of choice of outpatient appointment to our patients.The rate of Outpatient appointment cancellations by both the hospital and patients still remains a challenge for LTHT. The Outpatient CSU, is continuing to support CSUs with reducing clinic cancellations under 6 weeks, increasing the number of Outpatients appointments booked through choice and the development of SLAs with CSUs. There has been an increasing number of patients waiting over 3 months for follow up since February 2019. Analysis has been undertaken and CSU’s have been requested to review their over 3 month follow up and provide a plan to reduce these waiting times. This measure will also be introduced into CSU Delivery Contracts by the end of Q2 2019/20.
27
0
5000
10000
15000
20000
25000
OP Appointment Cancellations Cancelled By Hospital Cancelled By Patient inc CND
0
2000
4000
6000
8000
10000
12000
OP Follow-Up Waiting List Patients >3 Months Over their Due Date
5.0%
5.5%
6.0%
6.5%
7.0%
7.5%
8.0%
8.5%
Outpatient DNA% LTHT Peer Avg
Source:Dr Foster
CQC: Other Length of Stay
Standard(s): To reduce the length of stay in order to release capacity for other patients and provide an improved patient experience
Owner(s): Chief Operating Officer and Clinical Directors
Commentary: When reviewing the SPC charts, 99% of data points should fall between the Lower and Upper Control Limit:• Elective LOS SPC Charts is within normal control• The Non Elective LOS SPC Charts is within normal control.
28
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
Non-Elective Length of Stay
LOS (Days) Average LCL UCL
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
Elective Length of Stay
LOS (Days) Average LCL UCL
2.00
2.50
3.00
3.50
4.00
4.50
Ave
rag
e L
OS
Da
ys
Elective LOS LTHT Peer Avg
3.50
4.00
4.50
5.00
5.50
6.00
Ave
ra
ge
LO
S D
ays
Non-Elective LOS LTHT Peer Avg
CQC: Effective 30 Day Emergency Readmission Rates
Standard(s): Ensure no more than 10.9% of patients are readmitted as an emergency within 30 days of discharge, following elective or non-elective treatment.
Owner(s): Chief Operating Officer and CSU Clinical Directors
Commentary: Readmission rates remain below peer in elective, non-elective and total categories..
29
0%
2%
4%
6%
8%
10%
12%
14%
Jul-18 Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19
% Readmissions - elective
% Readmissions Peer % Readmissions
0%
2%
4%
6%
8%
10%
12%
14%
Jul-18 Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19
% Readmissions - non-elective
% Readmissions Peer % Readmissions
0%
2%
4%
6%
8%
10%
12%
14%
Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19 Apr-19 May-19 Jun-19 Jul-19
% Readmissions - total (elective and non-elective)
% Readmissions Peer % Readmissions
CQC: Other CQUIN Tracker – Page 1of 3
Standard(s): To ensure LTHT meets required CCG Nationally selected and locally agreed CQUIN requirements within defined timescales in order to access associated funding
Owner(s): Chief Nurse and Clinical Directors
Commentary: CCG & NHSE CQUINs 2019/20: IQPR 10 Sept 2019
30
CQC: Other CQUIN Tracker – Page 2 of 3
Standard(s): To ensure LTHT meets required CCG Nationally selected and locally agreed CQUIN requirements within defined timescales in order to access associated funding
Owner(s): Chief Nurse and Clinical Directors
Commentary: CCG & NHSE CQUINs 2019/20: IQPR 10 Sept 2019
31
CQC: Other CQUIN Tracker – Page 3 of 3
Standard(s): To ensure LTHT meets required CCG Nationally selected and locally agreed CQUIN requirements within defined timescales in order to access associated funding
Owner(s): Chief Nurse and Clinical Directors
Commentary: CCG & NHSE CQUINs 2019/20: IQPR 10 Sept 2019
32
Key
Not achieved Local assessment to be signed off
Partial achievement Achieved
CQC: Well-led People
Standard(s): Ensure staff turnover remains stableReduce sickness absence rates in line with the internally agreed trajectory
Owner(s): Director of Human Resources and Clinical Directors
Commentary: Turnover has reduced by 2% from November 17 to June 19 (latest available). The most common reasons for leaving (excluding training grade doctors) are “Voluntary Resignation - Other/NotKnown”, “Voluntary Resignation – Relocation” and “Voluntary Resignation – Promotion” which account for 62.8% of leavers.
33
Vo
lun
tary
Re
sig
na
tio
n -
Oth
er/
No
t K
no
wn
Vo
lun
tary
Re
sig
na
tio
n -
Re
loca
tio
n
Vo
lun
tary
Re
sig
na
tio
n -
Pro
mo
tio
n
Re
tire
me
nt A
ge
Vo
lun
tary
Re
sig
na
tio
n -
Wo
rk L
ife
Ba
lan
ce
Vo
lun
tary
Re
sig
na
tio
n -
To
un
de
rta
ke
fu
rth
er
ed
uca
tio
n o
r tr
ain
ing
Vo
lun
tary
Re
sig
na
tio
n -
He
alt
h
Vo
lun
tary
Ea
rly R
eti
rem
en
t -
wit
h A
ctu
ari
al
Re
du
cti
on
En
d o
f F
ixe
d T
erm
Co
ntr
act
-C
om
ple
tio
n o
f T
rain
ing
Sch
em
e
Em
plo
ye
e T
ran
sfe
r
Vo
lun
tary
Re
sig
na
tio
n -
Ch
ild
De
pe
nd
an
ts
Dis
mis
sal
-C
ap
ab
ilit
y
De
ath
in
Se
rvic
e
En
d o
f F
ixe
d T
erm
Co
ntr
act
-E
nd
of
Wo
rk
Re
qu
ire
me
nt
Re
du
nd
an
cy -
Co
mp
uls
ory
Re
du
nd
an
cy -
Vo
lun
tary
Vo
lun
tary
Re
sig
na
tio
n -
Ad
ult
De
pe
nd
an
ts
Vo
lun
tary
Re
sig
na
tio
n -
La
ck o
f O
pp
ort
un
itie
s
Re
tire
me
nt
-Il
l H
ea
lth
Vo
lun
tary
Ea
rly R
eti
rem
en
t -
no
Actu
ari
al
Re
du
cti
on
Dis
mis
sal
-C
on
du
ct
0%
20%
40%
60%
80%
100%
0
5
10
15
20
25
30
35
40
45
Cu
mu
lati
ve
%
FT
E
Reason
Leaving Reasons June2019
Vital Few Useful Many Cumulative% Cut Off % [42]
0%
2%
4%
6%
8%
10%
12%
14%
Jun 17 Jul 17 Aug 17 Sep 17 Oct 17 Nov 17 Dec 17 Jan 18 Feb 18 Mar 18 Apr 18 May 18 Jun 18 Jul 18 Aug 18 Sep 18 Oct 18 Nov 18 Dec 18 Jan 19 Feb 19 Mar 19 Apr 19 May 19 Jun 19
Turnover Rate (Jun-17 - Jun-19)
*Source iView – Not Comparable to internal figures due to counting some other organisations as part of the trust - This is the
last available data due to metric being retired.
Turnover May 2019
CQC: Well-led People
Standard(s): Ensure staff turnover remains stableReduce sickness absence rates in line with the internally agreed trajectory (AF and internal indicator)
Owner(s): Director of Human Resources and Clinical Directors
Commentary: A long term sickness is classed as any sickness over 28 consecutive days, a short term sickness is anything under this. The top 3 long term sickness absence reasons are “S10Anxiety/stress/depression/other psychiatric illnesses”, “S12 Other musculoskeletal problems” and “S98 Other known causes - not elsewhere classified” accounting for 55.4% of Long TermSickness Absence.The top 3 short term sickness absence reasons are “S25 Gastrointestinal problems”, “S10 Anxiety/stress/depression/other psychiatric illnesses” and “S13 Cold, Cough, Flu – Influenza”accounting for 43.6% of Short Term Sickness Absence.
34
0.0%
0.5%
1.0%
1.5%
2.0%
2.5%
3.0%
Jun 17 Jul 17 Aug 17 Sep 17 Oct 17 Nov 17 Dec 17 Jan 18 Feb 18 Mar 18 Apr 18 May 18 Jun 18 Jul 18 Aug 18 Sep 18 Oct 18 Nov 18 Dec 18 Jan 19 Feb 19 Mar 19 Apr 19 May 19 Jun 19
Sickness Rates (Jun-17 - Jun-19) Twelve Month Short Term % Twelve Month Long Term %
S10 A
nx
iety
/str
ess
/de
pre
ssi
on
/oth
er
psy
ch
iatr
ic
illn
ess
es
S12 O
the
r m
usc
ulo
ske
leta
l p
rob
lem
s
S98 O
the
r kn
ow
n c
au
ses
-n
ot
els
ew
he
re
cla
ssif
ied
S28 I
nju
ry,
fra
ctu
re
S99 U
nkn
ow
n c
au
ses
/ N
ot
spe
cif
ied
S11 B
ack P
rob
lem
s
S25 G
ast
roin
test
ina
l p
rob
lem
s
S17 B
en
ign
an
d m
ali
gn
an
t tu
mo
urs
, ca
nce
rs
S26 G
en
ito
uri
na
ry &
gyn
ae
co
log
ica
l d
iso
rde
rs
S13 C
old
, C
ou
gh
, F
lu -
Infl
ue
nza
S30 P
reg
na
ncy r
ela
ted
dis
ord
ers
S19 H
ea
rt,
ca
rdia
c &
cir
cu
lato
ry p
rob
lem
s
S15 C
he
st &
re
spir
ato
ry p
rob
lem
s
S16 H
ea
da
ch
e / m
igra
ine
S18 B
loo
d d
iso
rde
rs
S29 N
erv
ou
s sy
ste
m d
iso
rde
rs
S21 E
ar,
no
se,
thro
at
(EN
T)
S23 E
ye
pro
ble
ms
S31 S
kin
dis
ord
ers
S24 E
nd
ocri
ne
/ g
lan
du
lar
pro
ble
ms
S22 D
en
tal
an
d o
ral p
rob
lem
s
S27 I
nfe
cti
ou
s d
ise
ase
s
S14 A
sth
ma
0%
20%
40%
60%
80%
100%
0
1000
2000
3000
4000
5000
6000
7000
Cu
mu
lati
ve
%
Da
ys
Lo
st
Reason
Long Term Sickness Reasons June 2019
Vital Few Useful Many Cumulative% Cut Off % [42]
S25 G
ast
roin
test
ina
l p
rob
lem
s
S10 A
nx
iety
/str
ess
/de
pre
ssi
on
/oth
er
psy
ch
iatr
ic
illn
ess
es
S13 C
old
, C
ou
gh
, F
lu -
Infl
ue
nza
S99 U
nkn
ow
n c
au
ses
/ N
ot
spe
cif
ied
S98 O
the
r kn
ow
n c
au
ses
-n
ot
els
ew
he
re
cla
ssif
ied
S12 O
the
r m
usc
ulo
ske
leta
l p
rob
lem
s
S16 H
ea
da
ch
e / m
igra
ine
S11 B
ack P
rob
lem
s
S28 I
nju
ry,
fra
ctu
re
S21 E
ar,
no
se,
thro
at
(EN
T)
S30 P
reg
na
ncy r
ela
ted
dis
ord
ers
S26 G
en
ito
uri
na
ry &
gyn
ae
co
log
ica
l d
iso
rde
rs
S15 C
he
st &
re
spir
ato
ry p
rob
lem
s
S23 E
ye
pro
ble
ms
S22 D
en
tal
an
d o
ral p
rob
lem
s
S31 S
kin
dis
ord
ers
S27 I
nfe
cti
ou
s d
ise
ase
s
S19 H
ea
rt,
ca
rdia
c &
cir
cu
lato
ry p
rob
lem
s
S29 N
erv
ou
s sy
ste
m d
iso
rde
rs
S14 A
sth
ma
S24 E
nd
ocri
ne
/ g
lan
du
lar
pro
ble
ms
S17 B
en
ign
an
d m
ali
gn
an
t tu
mo
urs
, ca
nce
rs
S18 B
loo
d d
iso
rde
rs
0%
20%
40%
60%
80%
100%
0
200
400
600
800
1000
1200
1400
1600
Cu
mu
lati
ve
%
Da
ys
Lo
st
Reason
Short Term Sickness Reasons June 2019
Vital Few Useful Many Cumulative% Cut Off % [42]
Accountability
Framework Finance: Accountability Framework Dashboard
Owner(s): Director of Finance
35
Domain 2 - Finance
Aug-19
In-year financial delivery indicators Plan £'000 Actual £'000 Variance £'000
NHS Financial Performance
Year to Date, Actual compared to Plan (Control Total including PSF before the impact of gains on disposal of assets) (7,298) (5,654) 1,644
Forecast Outturn, Compared to Plan (Control Total including PSF before the impact of gains on disposal of assets) 12,007 12,007 0
Financial Efficiency
Actual Efficiency for Year to Date compared to Plan 13,142 13,172 30
Recurrent Efficiencies for Year to Date compared to Plan 10,776 9,231 (1,545)
Forecast Outturn Efficiency Compared to Plan 51,900 51,900 0
Recurrent Efficiencies for Forecast Outturn compared to Plan 41,051 35,824 (5,227)
Underlying Revenue Position
Forecast Outturn Underlying Revenue Position compared to plan (41,999) (47,226) (5,227)
Cash and Capital
Forecast Year End Charge to Capital Resource Limit (incl IFRS impact) 65,462 65,263 (199)
Temporary Working Capital Drawdown for Liquidity Purposes (cumulative sum) 0 0 0
Funding Accessed (cumulative sum) 0 0 0
Use of resources indicators Plan Actual Variance
Liquidity Days 4 4 0
Capital Services Capacity 4 4 0
I&E Margin 4 3 1
Variance from Control Total 1 1 0
Agency 1 1 0
Use of Resources Rating 3 3 0
SECTION A: NATIONAL KEY INDICATORS
In-Y
ea
r F
ina
nc
ial D
eliv
ery
Us
e o
f R
es
ou
rce
s
Ra
tin
g
36
Single Oversight
Framework Finance: In-year delivery
In-year Delivery The Trust delivered an operating deficit before Provider Sustainability Funding (PSF) and Marginal Rate Emergency Tariff (MRET) of £13.1 million for the fivemonths to 31st August 2019, £1.6m ahead of the plan. As the Trust has agreed to a control total with NHS England and NHS Improvement and has achievedits financial plan for August, it is eligible to receive PSF funding of £4.9 million in addition to MRET funding of £2.6 million which gives an overall deficit todate for the Trust of £5.7 million, ahead of plan by £1.6 million. Overall income at the end of August, £541.7 million, is ahead of plan by £7.8 million.Operating expenditure is £6.9 million behind plan with a £4.4 million adverse variance on pay and a £2.5 million adverse variance on non-pay. The non-payvariance includes an adverse variance against pass through drugs and blood of £3.8 million (offset in income), the non-pay non pass through is £1.3 millionfavourable to plan.
Savings of £2.3 million were delivered in August with savings to date of £13.2 million, which is slightly ahead of the plan by £0.1m. The savings plan for theyear is £51.9 million.
Accountability Framework
summary performance:In August the Trust reported a deficit of £5.7 million (including PSF and MRET) against a planned deficit of £7.3 million.
The Single Oversight Framework has four ratings/levels which are used by NHSI to determine which level of support would be of benefit to a trust:-1. No Concerns 2. Minor Concerns/Emerging Issues 3. Serious Issues 4. Critical Issues
The Trust achieved a use of resources risk rating of 3 in August.
Liquidity (weighting 20%) Liquidity at month end was -22 days which equates to a rating of 4 (against plan rating of 4)
Capital Servicing Capacity
(weighting 20%)Capital servicing capacity at month end was 0.93 which equates to a rating of 4 (against plan rating of 4).
I&E Margin (weighting 20%) I&E Margin at month end was (1.0%) which equates to a rating of 3 (against plan rating of 4).
Variance from Control Total
(weighting 20%)I&E Variance from control total at month end was 0.3% which equates to a rating of 1 (against plan rating of 1).
Agency Spend Distance
from Cap (weighting 20%)Agency Spend distance from capped plan at month end was (2.0%) which equates to a rating of 1 (against plan rating of 1).
Overall Use of Resources
(100%)Overall Use of Resources (after NHSI/NHSE overrides) at month end was rated at 3 (against plan rating of 3).
Appendix 1: Updates from Regulators
Provides a summary of important updates from regulatory and oversight bodies
Regulators Provider regulation – NHS Improvement regulates NHS foundation trusts and trusts on their financial stability, operational performance, care quality, leadership,
improvement capability and their ability to deliver strategic change. It does this through the Single Oversight Framework which combines powers previously exercised by
Monitor and the NHS Trust Development Authority (TDA).
Quality regulation – Quality regulation has risen up the agenda in recent years. As a result, the Care Quality Commission (CQC) has undergone significant reform. The CQC
sets the fundamental standards of quality and safety for healthcare services and monitors and inspects providers to ensure standards are upheld. The CQC's five year
strategy for 2016-21 sets out how its regulatory model will develop following the first inspection of all NHS providers.
NHS Improvement:
Join the conversation
on workforce
(February 2019)
NHS Improvement launched five discussion pages on Talk Health and Care asking:• How can we better support our clinical workforce?• How do we ensure the NHS is a great place to work?• How do we develop compassionate, effective and diverse leaders in the NHS?• The future medical workforce: How do we get the balance right?• How can we enable the delivery of the NHS Long Term Plan by improving skills and education in using new technology?Each week they post new questions via workforce bulletin.Share your views at: https://dhscworkforce.crowdicity.com/category/browse/
NHS Improvement
Provider Bulletins
Further in formation on the NHS Provider Bulletins is available on the NHS Improvement Website at:https://improvement.nhs.uk/news-alerts/?articletype=provider-bulletin
Care Quality
Commission: State of
Care 2017/18
(October 2018)
State of Care is our annual assessment of health and social care in England. This year's State of Care finds that most people receive a good quality of care, but that people’s experiences areoften determined by how well different parts of local systems work together.
Further information and the full report is available on the CQC Website at:https://www.cqc.org.uk/news/stories/state-care-201718-published
Care Quality
Commission: New
web resource on
effective staffing
(June 2019)
The CQC’s have published a new resource on the CQC’s website which explores the approaches taken by a range of health and social care providers to make effective use of their staff.
Further information and the full report is available on the CQC Website at:https://www.cqc.org.uk/news/stories/new-web-resource-effective-staffing
Care Quality
Commission: Latest
News
The latest news articles published by CQC can be found on the CQC Website at:http://www.cqc.org.uk/search/site/news
37
38
Appendix 2: Peer GroupsLists the providers used to benchmark performance throughout the report
HCAIBrighton & Sussex University HospitalsCambridge University HospitalsCentral Manchester University HospitalsChelsea & Westminster HospitalGuy's & St. Thomas'Imperial College HealthcareKing's College HospitalManchester University NHS Foundation TrustNottingham University HospitalsOxford University HospitalsPlymouth HospitalsRoyal Free HampsteadRoyal Liverpool & Broadgreen University HospitalsSalford RoyalSheffield Teaching HospitalsSouth Tees HospitalsSt. George's HealthcareThe Newcastle upon Tyne HospitalsUniversity College London HospitalsUniversity Hospital BirminghamUniversity Hospital SouthamptonUniversity Hospitals BristolUniversity Hospitals Coventry & WarwickshireUniversity Hospitals of Leicester
Diagnostics, Harm Free Care, Friends and Family Test, Complaints, OP DNA, OP New to Review, Length of Stay and VTECambridge University Hospitals NHS Foundation TrustManchester University NHS Foundation TrustNottingham University Hospitals NHS TrustOxford University Hospitals NHS TrustRoyal Liverpool & Broadgreen University Hospitals NHS TrustSheffield Teaching Hospitals NHS Foundation TrustThe Newcastle upon Tyne Hospitals NHS Foundation TrustUniversity Hospital Southampton NHS Foundation TrustUniversity Hospitals Birmingham NHS Foundation TrustUniversity Hospitals Bristol NHS Foundation TrustUniversity Hospitals of Leicester NHS Trust
RTT (as above, plus the following)Guy’s and St Thomas’ NHS Foundation Trust
Imperial College Healthcare NHS Trust
King’s College Hospital NHS Foundation Trust
University College London Hospitals NHS Foundation Trust
A&ECambridge University Hospitals NHS Foundation Trust
Manchester University NHS Foundation TrustNottingham University Hospitals NHS Trust
Oxford University Hospitals NHS Trust
Royal Liverpool & Broadgreen University Hospitals NHS Trust
Sandwell And West Birmingham Hospitals NHS Trust
Sheffield Teaching Hospitals NHS Foundation Trust
The Newcastle Upon Tyne Hospitals NHS Foundation Trust
University Hospitals Of Leicester NHS Trust
CancerCambridge University Hospitals NHS Foundation TrustManchester University NHS Foundation TrustNottingham University Hospitals NHS TrustSheffield Teaching Hospitals NHS Foundation TrustThe Christie NHS Foundation TrustThe Newcastle upon Tyne Hospitals NHS Foundation TrustThe Royal Marsden NHS Foundation TrustUniversity Hospitals Bristol NHS Foundation TrustUniversity Hospitals of Leicester NHS Trust
39
Appendix 3: GlossaryExplains any abbreviations used throughout the report
AFASICAHCASCCGCDICIPCEOCOOCQCCQUINCSUCUTIDBSDGHDHDNAEBITDAEDFFTFTGDPGMPHCAIHSMRI&EIMASIPTQPRKPILGILoSMDTMRSAMSSANIHR
Accountability FrameworkAppointment Slot IssueChapel Allerton HospitalCentral Alerting SystemClinical Commissioning GroupClostridium Difficile Infections Cost Improvement ProgrammeChief Executive OfficerChief Operating OfficerCare Quality CommissionCommissioning for Quality & InnovationClinical Service UnitCatheter-associated Urinary Tract Infection Directly Bookable ServicesDistrict General HospitalDepartment of HealthDid Not AttendEarnings Before Interest, Tax, Depreciation and AmortisationEmergency DepartmentFriends and Family TestFoundation TrustGeneral Dental PractitionersGeneral Medical PractitionersHealthcare Associated InfectionHospital Standardised Mortality RatioIncome & ExpenditureNHS Interim Management and SupportInter-Provider TransferQuality & Performance ReportKey Performance IndicatorLeeds General InfirmaryLength of StayMulti-Disciplinary TeamMeticillin Resistant Staphylococcus AureusMeticillin Sensitive Staphylococcus AureusNational Institute for Health Research
PDCR&IRAFRAGRCARTTSHMISJUHTBCTDAVTEWHOYASYTD
Public Dividend CapitalResearch & InnovationRisk Assessment FrameworkRed Amber GreenRoot Cause AnalysisReferral to TreatmentSummary Hospital-level Mortality IndicatorSt James's University HospitalTo Be ConfirmedTrust Development AuthorityVenous ThromboembolismWorld Health OrganisationYorkshire Ambulance ServiceYear to Date
In order to provide assurance of the quality ofdata presented in this report, a data qualitymatrix has been developed and appliedthroughout. The matrix is based on the 6dimensions of data quality (accuracy, validity,reliability, timeliness, relevance, andcompleteness), with indicators reviewed on anannual basis.
The icon displayed to the left is featured on pages whose content has been assessed and approved against the matrix.